Method of treating or inhibiting glucose intolerance
AssigneesPresident and Fellows of Harvard College, The Brigham and Women's Hospital, Inc.
InventorsOrnella Barrandon, Tommaso Poggioli, Douglas A. Melton, Richard T. Lee
Life of this patent
Estimating the term…
Abstract
Disclosed herein are a means to prevent and/or ameliorate age, disease and obesity associated metabolic diseases, such as diabetes and impaired glucose tolerance. Also disclosed are compositions and methods that relate to the findings that GDF11 prevents weight gain, improves glucose tolerance and reduces hepatosteatosis in aged mice administered a high fat diet. In particular, the methods and compositions described herein relate to increasing the level of GDF11 in a subject, thereby treating or preventing the development of obesity in the subject, reducing the metabolic consequences of obesity and improving the subject's metabolic health.
Claims19
A method of inhibiting or treating glucose intolerance in a subject in need thereof, the method comprising administering to the subject a composition comprising an amount of Growth Differentiation Factor 11 (GDF11) polypeptide or a functional fragment thereof effective to inhibit or treat glucose intolerance in the subject.
Dependencies are inferred from the claim text.